Venture Life begins trading on AIM

Healthcare company Venture Life Group started its first day of trading on AIM on Friday following fundraising of 5.4m pounds.The company, focused on developing products for the ageing population, issued 24.26m ordinary shares, giving the group a market capitalisation of £26.4m at the placing price.The fundraising and admission to AIM allowed Venture Life to complete the acquisition of, Biokosmes Srl, an Italian company which develops and manufactures topical products, including cosmetics, dermo-cosmetics and medical devices.Jerry Randall, Chief Executive Officer of Venture Life, said: "Venture Life is delighted to be joining AIM and we look forward to continuing to grow Venture Life by capitalising on the increasing demands of the ageing population for healthcare products and food supplements. "We are also very pleased to welcome Biokosmes to the group as we look to bring together Venture Life's expertise in brand and product development, and commercialisation, with Biokosmes's extensive knowledge and expertise in topical product development and manufacturing."Shares were at 107.50p at 15:51 on Friday compared to the opening price of 112.50p. RD